|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Stability of SARS Coronavirus in Human Specimens and Environment and Its Sensitivity to Heating and UV Irradiation显示文摘The causal agent for SARS is considered as a novel coronavirus that has never been described both in human and animals previously. The stability of SARS coronavirus in human specimens and in environments was studied. Methods Using a SARS coronavirus strain CoV-P9,which was isolated from pharyngeal swab of a probable SARS case in Beijing, its stability in mimic human specimens and in mimic environment including surfaces of commonly used materials or in household conditions, as well as its resistances to temperature and UV irradiation were analyzed. A total of 106 TCID50 viruses were placed in each tested condition, and changes of the viral infectivity in samples after treatments were measured by evaluating cytopathic effect (CPE) in cell line Vero-E6 at 48 h after infectionn. Results The results showed that SARS coronavirus in the testing condition could survive in serum, 1:20 diluted sputum and feces for at least 96 h, whereas it could remain alive in urine for at least 72 h with a low level of infectivity. The survival abilities on the surfaces of eight different materials and in water were quite comparable, revealing reduction of infectivity after 72 to 96 h exposure. Viruses stayed stable at 4℃, at room temperature (20℃) and at 37℃ for at least 2 h without remarkable change in the infectious ability in cells, but were convened to be non-infectious after 90-, 60- and 30-min exposure at 56℃, at 67℃ and at 75℃, respectively. Irradiation of UV for 60 min on the virus in culture medium resulted in the destruction of viral infectivity at an undetectable level. Conclusion The survival ability of SARS coronavirus in human specimens and in environments seems to be relatively strong. Heating and UV irradiation can efficiently eliminate the viral infectivity. | SHU-MING DUAN, XIN-SHENG ZHAO, RUI-FU WEN, JING-JING HUANG, GUO-HUA PI, SU-XIANG ZHANG, JUN HAN, SHENG-LI BI, LI RUAN, XIAO-PING DONGAND SARS RESEARCH TEAMInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention,Ying-Xin Rd. 100, Beijing 100052, China | 2003 | Biomedical and Environmental Sciences2003，16，3： | 29 |
| 2 | A study of recombinant protective H.Pylori antigens显示文摘AIM: To construct a recombinant vector which can express Mr 26 000 outer membrane protein (OMP) from Helicobacter pylori (Hp), and to obtain the vaccine protecting against Hp infection and a diagnostic reagent kit quickly detecting Hp infection.METHODS: The gene encoding the structural Mr 26000 outermembrane protein of Hp was amplified from Hpchromosomal DNA by PCR, and inserted in the prokaryoticexpression vector pET32a ( + ), which was transformed intothe Topl0 E. coli strain. Recombinant vector was selected,identified and transformed into BL-21(DE3) E. coli strain.The recombinant fusion proteins were expressed. Theantigenicity of recombinant protein was studied by ELISA orimmunoblotting and immunized Balb/c mice.RESULTS: The gene of Mr 26 000 OMP was amplified to be594 base pairs, 1.1% of the cloned genes was mutated and1.51% of amino acid residues was changed, but there washomogeneity between them. The recombinant fusion proteinencoded objective polypeptides of 198 amino acid residues,corresponding to calculated molecular masses of Mr 26000.The level of soluble expression products was about 38.96 %of the total cell protein. After purification by Ni-NTA agaroseresin columniation, the purity of objective protein becameabout 90 %. The EESA results showed that recombinantfusion protein could be recognized by patient serum infectedwith Hp and rabbit serum immunized with the recombinantprotein. Furthermore, Balb/ c mice immunized with therecombinant proteln were protected against H. pyloriinfection.CONCLUSION: Mr 26 000 OMP may be a candidate vaccinepreventing Hp infection. | Zheng Jiang Xiao-Hong Tao Pi-Long Wang,Department of Gastroenterology,the First Affiliated Hospital,Chongqing University of Medical Sciences,Chongqing 400016,China Ai-Long Huang,Institute of Viral Hepatitis,Chongqing University of Medical Sciences,Chongqing 400010,China | 2002 | World Journal of Gastroenterology2002，8，2： | 20 |
| 3 | Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma显示文摘Epstein-Barr virus (EBV) infection has been causally associated with occurrence of many malignant neoplasms. EBV-encoded small RNAs (EBERs) have been detected from about 10% of gastric carcinoma tissue cells, suggesting that EBV infection is associated with the development of gastric carcinoma. The present study pooled the data from the papers concerning EBV-related gastric cancers and performed a meta-analysis of 22 research papers. Among these papers, a total of 5475 cases with gastric cancer were enrolled, of whom 411 cases were found EBV-positive, with the EBV-positive rate being 7.5%. Among the EBV-positive gastric cancer cases, the detection rate was 11.1% in males and 3.0% in females. Compared with EBV-negative gastric cancer, EBV-positive gastric cancer had less lymph node metastasis. Based on the histological typing, of the EBV-positive gastric cancers, the diffuse type was 8.1%, and intestinal type was 8.0%. The examined specimen types included stored paraffin blocks and fresh surgically removed specimens, their EBV positive rates were 7.9% and 6.5% respectively. In terms of geographical distribution, the detection rate of EBV-positive gastric cancer was 9.4% in America, 6.1% in Asia and 9.1% in Europe. Meta-analysis showed that EBV infection occurred only in gastric cancer tissue cells and was significantly associated with the patients’ gender, lymph node metastases, and the location where tumor tissue generated and geographical distribution (P<0.05), but was not significantly associated with the patients’ histological types of tumor and the types of specimens (P>0.05). These results suggested that EBV-positive gastric cancer has distinct clinicopathological features. | LI ShuYing1,2, DU HaiJun3, WANG Zhan3, ZHOU Ling3, ZHAO XiaoYu1 & ZENG Yi3 1 College of Life Sciences, Hebei University, Baoding 071002, China 2 Department of Pathogenic Biology, Faculty of Biological Science, North China Coal Medical College, Tangshan 063000, China 3 National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (Chinese CDC), State Key Laboratory for Infectious Disease Prevention and Control (SKLID), Beijing 100052, China | 2010 | Science China(Life Sciences)2010，53，4： | 17 |
| 4 | Human avian influenza A (H5N1) virus infection in China显示文摘Highly pathogenic influenza A (H5N1) virus causes a widespread poultry deaths worldwide. The first human H5N1 infected case was reported in Hong Kong Special Administrative Region of China in 1997. Since then, the virus re-emerged in 2003 and continues to infect people worldwide. Currently, over 400 human infections have been reported in more than 15 countries and mortality rate is greater than 60%. H5N1 viruses still pose a potential pandemic threat in the future because of the continuing global spread and evolution. Here, we summarize the epidemiological, clinical and virological characteristics of human H5N1 infection in China monitored and identified by our national surveillance systems. | XU CuiLin, DONG LiBo, XIN Li, LAN Yu, CHEN YongKun, YANG LiMei & SHU YueLong State Key Laboratory for Viral Genetic and Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 100052, China | 2009 | Science China(Life Sciences)2009，52，5： | 14 |
| 5 | Study on interaction between microtubule associated protein tau and prion protein显示文摘Microtubule-associated protein tau is considered to play roles in many neurodegenera-tive diseases including some transmissible spongiform encephalopathies.To address the possible molecular linkage of prion protein(PrP) and tau,a GST-fusion segment of human tau covering the three-repeat region and various PrP segments was used in the tests of GST pull-down and immuno-precipitation.We found tau protein interacted with various style prion proteins such as native prion protein(PrPC) or protease-resistant isoform(PrPSc) .Co-localization signals of tau and PrP were found in the CHO cell tranfected with both PrP and tau gene.The domain of interaction with tau was located at N-terminal of PrP(residues 23 to 91) .The evidence of molecular interactions between PrP and tau protein highlights a potential role of tau in the biological function of PrP and the pathogenesis of TSEs. | HAN Jun1,ZHANG Jin1,2,YAO Hailan1,3,WANG Xiaofan1,LI Feng1,CHEN Lan1,4,GAO Chen1,GAO Jianmei1,NIE Kai1,ZHOU Wei1 & DONG Xiaoping11.State Key Laboratory for Infectious Diseases Prevention and Control,National Institute for Viral Disease Control and Pre-vention,Chinese Center for Disease Control and Prevention,Beijing 100052,China 2.School of Medicine,Xi’an Jiao-Tong University,Xi’an 710061,China 3.Tong-Ji Medical College,Hua-Zhong University of Science and Technology,Wuhan 430030,China 4.National Laboratory of Medical Molecular Biology,Institute of Basic Medical Science,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100005,China | 2006 | Science China(Life Sciences)2006，49，5： | 10 |
| 6 | Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation显示文摘BACKGROUND: Liver allograft hepatitis B virus (HBV) reinfection and hepatitis B (HB) recurrence jeopardize the long-term survival of recipient and liver allograft. Lamivu- dine has been referred as a novel antiviral agent against HBV in HBV cirrhotic patients even in liver transplantation setting. We assessed the prophylatic effect of lamivudine on liver allograft HBV reinfection and clarified the dynamic changes of HBV markers in HBV related decompensated liver cirrhosis after liver transplantation. METHODS: Twenty-five recipients were divided into three groups: HBV active replication group (15 recipients), HBV inactive replication group (7), and control group (3). 100 mg/d lamivudine was administered preoperatively except in the control group. The HBV markers of serial sera and liver biopsy samples of the 25 recipients were evaluated re- gularly with enzyme-linked radioimmunoassay, HBV DNA fluorecent quantitative assay, immunohistochemical stain- ing , labelled streptavidin biotin ( LSAB) and digoxin la- belled HBV DNA hybridization in situ. The dynamic alter- nation of HBV markers under lamivudine prophylaxis was observed. RESULTS: In the HBV active replication group who had received lamivudine 2 weeks before liver transplantation, serum HBV DNA positive converted to negative by 80%. HBsAg of all recipients disappeared after liver transplanta- tion , but corresponding antibodies of HBV appeared within one week after the operation. HBsAb 9/15, HBcAb 13/15 and HBeAb 11/15 appeared and subsided gradually within 24 weeks. HBV DNA in sera was kept negative; HBsAg, HBcAg and HBV DNA hybridization in situ of liver biopsy samples remained negative after use of lamivudine. Ten of the 15 recipients showed clearance of HBV, and per se HBV markers were undetectable both in serum and liver bi- opsy samples between 12 to 44 weeks (24 weeks on ave- rage). The 1-, 2-year survival rates were 83% in this group. Two of the 15 recipients developed HBV allograft reinfection or recurrence of hepatitis 2 years after lamivudi- ne monoprophylaxis (2/15, 13.3%). In the HBV inactive replication group, the outcome was similar to that of the HBV active group. The HBV antibody frequency was HBs- Ab 4/7, HBcAb 6/7, and HBeAb 2/7. Three of 7 recipients showed HBV clearance both in sera and liver biopsy sam- ples , whereas in the control group all 3 recipients developed HBV allograft reinfection and recurrent hepatitis 8, 10, 12 months postoperatively; one of them died of fibrosing cho- lestatic hepatitis, and the remaining 2 recovered after addi- tional lamivudine therapy. The overall allograft reinfection rate was 9.1% (2/22) and the overall 1-, 2-year survival rates were 87%) in the lamivudine prophylaxis group. CONCLUSIONS: Lamivudine prophylaxis can prevent ef- fectively liver allograft from HBV reinfection in patients with HBV-related decompensated liver cirrhosis even in HBV active replication recipient after liver transplantation. Its long-term outcome remains to be studied. | Shi-Chun Lu, Lu-Nan Yan, Bo Li, Tian-Fu Wen, Ji-Chun Zhao, Nan-Sheng Cheng, Chong Liu, Jun Liu, Xiao-Bo Wang, Xiao-Dong Li, Shan Qin, Lian-Shan Zhao, Bin-Jun Lei and Xiu-Hui Zhang Chengdu, China Department of Surgery Viral Hepa- titis Research Center Department of Pathology , West China Hospital, Sichuan University, Cheng- du 610041 , China | 2004 | Hepatobiliary & Pancreatic Diseases International2004，3，1： | 9 |
| 7 | Is cash negative debt? A hedging perspective on corporate financial policies显示文摘 | Viral V. Acharya Heitor Almeida Murillo Campello | 2007 | Journal of Financial Intermediation2007，，4： | 6 |
| 8 | Functional analysis of transcriptional regulation of herpes simplex virus type 1 tegument protein VP22显示文摘The herpes simplex virus type 1 (HSV-1) tegument proteins have important functions in the viral repli- cation process. In order to investigate the role of the HSV-1 tegument protein VP22 in viral replication, its transcriptional regulation of viral promoters was investigated using the chloramphenicol acetyl- transferase (CAT) assay. The results indicate that VP22 exerts a dose-dependent transcriptional in- hibitory effect on the HSV-1 α4, TK, and gC gene promoters. VP22 had the capacity to repress tran- scriptional activation of promoters via different viral transcription regulatory factors such as VP16 and ICP0, as evidenced by the specific repression of the TK and gC gene promoters by ICP0. In addition, VP22 was capable of inhibiting the promotion of ICP0 transcriptional activation in the presence of HAT PCAF, which is even more remarkable than the VP22 repression of ICP0 transcriptional activation. Fi- nally, the transcriptional inhibitory effect of VP22 on other viral promoters was demonstrated by the analysis of β-galactosidase activities in internal controls. | YU Xian1,2, LI WeiZhong1, LIU LongDing1, CHE YanChun1, CUN Wei1, WU WenJuan1, HE ChunYan1, SHAO CongWen1 & LI QiHan1 1 Department of Viral Immunology, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China 2 Institute of Materia Medica, North Sichuan Medical College, Nanchong 637007, China | 2008 | Science China(Life Sciences)2008，51，11： | 4 |
| 9 | Anal cancer in Chinese:human papillomavirus infection and altered expression of p53显示文摘AnalcancerinChinese:humanpapilomavirusinfectionandalteredexpressionofp53LAIMaoDe,LUOMinJie,YAOJianErandCHENPeiHuiSubject... | LAI MaoDe, LUO MinJie, YAO JianEr and CHEN PeiHuiKeywords anus neoplasms papillomavirus infection DNA, viral p53 gene gene expression polymerase chain reaction | 1998 | World Journal of Gastroenterology1998，4，4： | 4 |
| 10 | Biomarkers of Alzheimer’s disease in body fluids显示文摘Various innovative diagnostic methods for Alzheimer’s disease (AD) have been developed in view of the increasing preva-lence and consequences of later-life dementia. Biomarkers in cerebrospinal fluid (CSF) and blood for AD are primarily based on the detection of components derived from amyloid plaques and neurofibrillary tangles (NFTs). Published reports on CSF and blood biomarkers in AD indicate that although biomarkers in body fluids may be utilized in the clinical diagnosis of AD, there are no specific markers that permit accurate and reliable diagnosis of early-stage AD or the monitoring of disease pro-gression. | ZHENG YanPeng1, HE JinSheng1 & HONG Tao1,2 1 College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China 2 Institute for Viral Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing 100052, China | 2010 | Science China(Life Sciences)2010，53，4： | 4 |
| 11 | Comparative analysis of whole genome structure of Streptococcus suis using whole genome PCR scanning显示文摘An outbreak associated with Streptococcus suis infection in humans emerged in Sichuan province, China in 2005. The outbreak is atypical for the apparent large number of human cases, high fatality rate and geographical spread. To determine whether the bacterium has changed, we compared both human and animal isolates from the Sichuan outbreak with those collected previously within China and in other countries using whole genome PCR scanning (WGPScaning) comparative sequencing of several known virulence factor genes and multilocus sequence typing (MLST) analysis. WGPScanning analysis showed that all primer pairs yielded PCR products of the expected sizes in all four strains tested. The nucleotide sequences of all the detected virulence factor genes are identical in the four strains and MLST results showed that the four isolates studied and reference strain all belonged to the ST1 com-plex. No new genetic changes were found in the genome structure of the isolates from this Sichuan outbreak. | XIONG ZhaoHui1*, WEI CanDong1*, YANG Jian1, PENG JunPing1, XU XingYe1, WANG Yu2 & JIN Qi1,3 1 State Key Lab for Molecular Virology and Genetic Engineering, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100176, China 2 Chinese Center for Disease Control and Prevention, Beijing 100050, China 3 Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Beijing 100730, China | 2008 | Science China(Life Sciences)2008，51，1： | 4 |
| 12 | Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation显示文摘BACKGROUND: Cytomegalovirus (CMV) infection is the important cause affecting the survival rate and function of the transplanted organ after transplantation. The occurrence of CMV infection after liver transplantation (LT) is associated with many factors. Lots of studies suggest that genetic mutation between hosts and CMV may play a role in the occurrence and development of CMV infection. CMV exists in an incubative state, affect or destroy the expression of human leukocyte antigen (HLA) molecules in the host cell surface, and interfere antigen’s submission. This mechanism is the key of CMV to avoid immune defense mechanism of the host. To detect HLA and CMV antibody (CMV-Ab), CMV antigen (CMV-Ag) of transplantation recipients, we evaluated the association of CMV infection and the particular HLA genotypes in recipients after LT. METHODS: 277 blood samples were collected from 39 LT recipients. CMV antibody and antigen were detected by ELISA or immunohistochemical methods. The HLA types of the recipients were determined by PCR. To analyze the association of HLA alleles and the occurrence of CMV antigenemia in the patients, relative risk degree (RR) was used as the parameter for the Chi-square test. RESULTS: The LT recipients were serum CMV IgG positive (100%), but none of them was CMV IgM positive (0%). Thirty-three LT recipients (84.6%) were CMV antigenic positive with 1-50 positive leukocytes per 50000 leukocytes in extent and 7.2±4.2 positive leukocytes per 50000 leukocytes on average. Thirteen patients developed CMV pneumonia, with CMV antigenic positive (100%) and 17.7±5.5 positive leukocytes per 50000 leukocytes on average. Some HIA alleles were associated with the occurrence and extent of CMV antigenemia. HLA-A2 was the higher frequency allele for patients with antigenemia (P<0.05), and 7 patients carrying HLA-DR11 allele developed antigenemia (P<0.05). In the lower antigenemia group, HLA-A11 was higher in frequency than others (P<0.05). Besides, none of the patients carrying HLA-B16 allele developed clinical symptoms of CMV infection (P<0.05). CONCLUSIONS: The variability of HLA alleles might modulate immune response to CMV infection. HLA examination before transplantation should be made for prevention and treatment of CMV infection aider operation. | Jun Fan, Xue-Qin Meng, Mei-Fang Yang, Lin Zhou, Xiao-Ming Chen, Min-Jun Hu, Wei-Wei Fan, Wei-Hang Ma and Lan-Juan Li Key Laboratory of Viral Infectious Diseases, Ministry of Public Health, Institute of Infectious Diseases Organ Transplantation Center First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003. China | 2006 | Hepatobiliary & Pancreatic Diseases International2006，5，1： | 3 |
| 13 | PrP mutants with different numbers of octarepeat sequences are more susceptible to the oxidative stress显示文摘One of the physiological functions of cellular prion protein(PrP C )is believed to work as a cellular resistance to oxidative stress,in which the octarepeats region within PrP plays an important role.However,the detailed mechanism is less clear.In this study,the expressing plasmids of wild-type PrP (PrP-PG5)and various PrP mutants containing 0(PrP-PG0),9(PrP-PG9)and 12(PrP-PG12)octarepeats were generated and PrP proteins were expressed both in E.coli and in mammalian cells.Protein aggregation and formation of carbonyl groups were clearly seen in the recombinant PrPs expressed from E.coli after treatment of H2O2.MTT and trypan blue staining assays revealed that the cells expressing the mutated PrPs within octarepeats are less viable than the cells expressing wild-type PrP.Statistically significant high levels of intracellular free radicals and low levels of glutathione peroxidase were observed in the cells transfected with plasmids containing deleted or inserted octarepeats.Remarkably more productions of carbonyl groups were detected in the cells expressing PrPs with deleted and inserted octarepeats after exposing to H2O2.Furthermore,cells expressing wild-type PrP showed stronger resistant activity to the challenge of H2O2 at certain extent than the mutated PrPs and mock. These data provided the evidences that the octarepeats number within PrP is critical for maintaining its activity of antioxidation.Loss of its protective function against oxidative stress may be one of the possible pathways for the mutated PrPs to involve in the pathogenesis of familial Creutzfeldt-Jacob diseases. | AN Run1 ,2,DONG ChenFang 2,LEI YanJun 1,2,HAN Lu 2,LI Ping 2,CHEN JianMing 2,WANG GuiRong 2, SHI Qi 2 ,GAO Chen 2 ,JIANG HuiYing 2 ,ZHOU Wei 2 ,HAN Jun 2 ,CHU YongLie 1 ,DONG XiaoPing 2 1School of Medicine,Xi’an JiaoTong University,Xi’an 710061,China 2State Key Laboratory for Infectious Disease Prevention and Control,National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention,YingXin Rd 100,Beijing 100052,China | 2008 | Science China(Life Sciences)2008，51，7： | 3 |
| 14 | Relationship between the different replication status of HBV and mutations in the core promoter in mothers and their children infected via mother-to-infant transmission显示文摘OBJECTIVE: To study the relationship between the different replication status of hepatitis B virus(HBV) and mutations in the core promoter (CP) in mother and her child infected by mother-to-infanttransmission.METHODS: The core promoter was amplified by PCR and cloned into pGEM-T vector with the T-Achoning technique. The recombinant plasmid pGEM-CP was confirmed by digestion with restrictionenzyme Apa I and Sac I. Two clones were selected to be sequenced in each patient.RESULTS: Every pair of mother and child had same serotype and genotype and the homology ofnucleotides encoding 'a' determinant was 98%-100%. The number of mutations in the core promoter ofpatients with a high replication status was less than that in those with a low replication status. Mutationswere mainly distributed in basia core promoter (BCP) and the inbibitor region of Kunitz-type serineprotease. This difference was not associated with mother or child.CONCLUSION: The different replication status of HBV is caused by mutations in the core promoter inmother and child infected hy mother-to-infant transmission and appears to be not associated with the statusof development of the infection. | Hong-Mei Xu Yu-Ling Qing Ming-Li Peng Ning Ling Hong Ren the Research Institute of Viral Hepatitis, Chongqing Medical University, Chongqing 400010, China | 2003 | Hepatobiliary & Pancreatic Diseases International2003，2，4： | 3 |
| 15 | Immediate-early gene product ICP22 inhibits the trans-transcription activating function of P53-mdm-2显示文摘As a product of HSVI immediate-early gene, ICP22 is capable of interacting with various cellular tran-scriptive and regulatory molecules during viral infection so as to impact the normal cellular molecular mechanism. ICP22 expressed in transfected cells can push the cells’ entering into S phase with binding to mdm-1 promoter region and impact its trans-transcription activating effect by P53. Consequently, the MDM-2 binds to P53, and the degradation effects by the ubiquitous pathway are decreased, improving indirectly the P53 levels in cells and making the cells progress into the S phase. | GUO HongXiong, CUN Wei, LIU LongDing, WANG LiChun, ZHAO HongLing, DONG ChengHong & LI QiHan Department of Viral Immunology, Institute of Medical Biology, CAMS and PUMC, Kunming 650118, China These authors contributed equally to this work | 2007 | Science China(Life Sciences)2007，50，4： | 2 |
| 16 | Formulation development and characterization of cellulose acetate nitrate based propellants for improved insensitive munitions properties显示文摘Cellulose acetate nitrate(CAN) was used as an insensitive energetic binder to improve the insensitive munitions(IM) properties of gun propellants to replace the M1 propellant used in 105 mm artillery charges.CAN contains the energetic nitro groups found in nitrocellulose(NC),but also acetyl functionalities,which lowered the polymer's sensitivity to heat and shock,and therefore improved its IM properties relative to NC.The formulation,development and small-scale characterization testing of several CAN-based propellants were done.The formulations,using insensitive energetic solid fillers and high-nitrogen modifiers in place of nitramine were completed.The small scale characterization testing,such as closed bomb testing,small scale sensitivity,thermal stability,and chemical compatibility were done.The mechanical response of the propellants under high-rate uni-axial compression at,hot,cold,and ambient temperatures were also completed.Critical diameter testing,hot fragment conductive ignition(HFCI) tests were done to evaluate the propellants' responses to thermal and shock stimuli.Utilizing the propellant chemical composition,theoretical predictions of erosivity were completed.All the small scale test results were utilized to down-select the promising CAN based formulations for large scale demonstration testing such as the ballistic performance and fragment impact testing in the105 mm M67 artillery charge configurations.The test results completed in the small and large scale testing are discussed. | Thelma MANNING Jeffrey WYCKOFF Carlton ADAM Eugene ROZUMOV Kenneth KLINGAMAN Viral PANCHAL Joseph LAQUIDARA Mike FAIR John BOLOGNINI Keith LUHMANN Steve VELARDE Christine KNOTT Stephanie M.PIRAINO Kevin BOYD | 2014 | Defence Technology(防务技术)2014，10，2： | 2 |
| 17 | Enhanced propellant performance via environmentally friendly curable surface coating显示文摘Surface coating of granular propellants is widely used in a multiplicity of propellants for small, medium and large caliber ammunition. All small caliber ball propellants exhibit burning progressivity due to application of effective deterrent coatings. Large perforated propellant grains have also begun utilizing plasticizing and impregnated deterrent coatings with the purpose of increasing charge weights for greater energy and velocity for the projectile. The deterrent coating and impregnation process utilizes volatile organic compounds(VOCs) and hazardous air pollutants(HAPs) which results in propellants that need to be forced air dried which impacts air quality. Propellants undergo temperature fluctuations during their life. Diffusion coefficients vary exponentially with variations in temperature. A small temperature increase can induce a faster migration, even over a short period of time, which can lead to large deviations in the concentration. This large concentration change in the ammunition becomes a safety or performance liability. The presence of both polymeric deterrents and nitroglycerin(NG) in the nitrocellulose matrix and organic solvents leads to higher diffusion rates. This results in continued emissions of VOCs and HAPs. Conventional polymers tend to partition within the propellant matrix. In other words,localized mixing can occur between the polymer and underlying propellant. This is due to solvent induced softening of the polymer vehicle over the propellant grain. In effect this creates a path where migration can occur. Since nitrate esters, like NG, are relatively small, it can exude to the surface and create a highly unstable and dangerous situation for the warfighter. Curable polymers do not suffer from this partitioning due to 'melting' because no VOC solvents are present. They remain surface coated. The small scale characterization testing, such as closed bomb testing, small scale sensitivity, thermal stability,and chemical compatibility, will be presented. The 30 mm gun demonstration firing data at hot, cold, and ambient temperatures will also be presented. | Thelma Manning Jeffrey Wyckoff Kenneth Klingaman Viral Panchal Eugene Rozumov John Bolognini Ming Wang Young Subhash Patel | 2017 | Defence Technology(防务技术)2017，13，3： | 2 |
| 18 | An algorithm for generating geometric buffers for vector feature layers显示文摘The paper presents an algorithm for constructing geometric buffers for vector feature layers and dissolving those buffers using a sweep-line approach and vector algebra.The algorithm works by first constructing a geometric buffer for a vector feature layer,then dissolving each single geometric buffer for that feature layer,and finally dissolving the overlapping buffers of the entire layer.The algorithm has been implemented successfully in a commercial Geographical Information System software package. | Sumeet BHATIA Viral VIRA Deepak CHOKSI P.VENKATACHALAM | 2013 | Geo-Spatial Information Science2013，16，2： | 2 |
| 19 | Review and Analysis of PEM Fuel Cell Design and Manufacturing显示文摘 | Viral Mehta Joyce Smith Cooper | 2003 | J Power Sources2003，114，1： | 1 |
| 20 | Pulmonary mucormycosis in a diabetic patient with HIV显示文摘 | VIRALLY ML RIVELINE JP VIRALLY J | 2002 | Diabetes Care2002，25，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员